More than 1,500 posters are scheduled for inclusion as part of TLMdX. Posters will be arranged per topic and the specific number assignment provided in the official notification letter.
All poster presenters will receive a link in early October to upload their posters. The link will be active the week of October 8-15. All posters MUST be uploaded by October 15, or they will not be included in TLMdX.
All poster presenters of The Liver Meeting Digital Experience™ are required to:
* You must register for the Annual Meeting by September 23 to receive advance registration rates. Access into The Liver Meeting Digital Experience™ sessions, posters, or exhibitors will not be permitted without registering for TLMdX.
Review the "Preparing Content and Deliverables" tab to assist you in preparing for your session.
You can access important information related to your role(s) at The Liver Meeting Digital Experience™ using the Speaker Center. Use your AASLD login information to access your Speaker Center.
A poster session is comprised of simultaneous informal presentations by several investigators. To communicate with all interested attendees, the best approach is to minimize the specific details presented on the poster and to maximize the transfer of information by creating an audio file to accompany your poster. Remember that your scientific message must be legible and clearly stated to the viewer.
PREPARE YOUR DIGITAL POSTER
File Type
Posters should not exceed 2GB in size. The preferred file types are PDF or PowerPoint (PPT). The full list of acceptable file types includes PPTX, PDF, MP4, MOV, MP3, DOCX, JPG, JPEG, and PNG.
Poster presenters will also have the opportunity to upload an OPTIONAL audio file to accompany their posters to describe their work. Audio files must be provided in MP3 format. It is recommended that audio files be approximately 5 minutes in length.
Formatting
Recommended minimum font-size: 28 pt
Recommended font types: Calibri, Arial, Times New Roman
Landscape format
Heading
The heading indicates the title of the paper, author(s), institution, and location.
Depicting Sections
Each section can be numbered with text in a font size to guide the attendee through your poster. Color is an effective method for separating sections and adding graphic impact. Try to avoid color combinations that are difficult to read.
Premise
Your poster should include three-to-five brief sentences outlining the information necessary to understand the study, and why it was done. The question(s) to be asked or the hypotheses to be tested should be clearly and succinctly stated.
Methods
Outline your methods briefly, providing only details for new methods, or modifications of older methods.
Graphics
Results presented in the form of a graph or chart are always more effective than blocks of text. Provide a legend for symbols and other details, and interpretation of results below each panel.
Conclusion
State the conclusion succinctly in large type. (Many viewers read this first, so it should be concise and easy to understand.)
Disclosure Policy
All faculty members (including Program Planners, Program Chairs, Moderators, Panelists, and Presenters) are expected to fully disclose all financial relationships with a commercial interest. By accepting our invitation, you agreed to comply with AASLD's Disclosure Policy and the ACCME Standards for Commercial Support in the planning, development, and presentation of educational activities.
Presentations may be recorded for printed and electronic distribution by AASLD. This includes posting on the eLearning portal LiverLearning®, and any AASLD affiliated websites and printed communications. If a course is selected for recording, presenters will have the ability to accept or decline this policy prior to the meeting.
OFF-LABEL, INVESTIGATIONAL USE
When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is included in the content of the educational activity, you are required to verbally disclose that the product is not labeled for the use under discussion or that the product is still investigational, in accordance with the ACCME standards and the Food and Drug Administration requirements.
Embargo Policy
When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is included in the content of the educational activity, you are required to verbally disclose that the product is not labeled for the use under discussion or that the product is still investigational, in accordance with the ACCME standards and the Food and Drug Administration requirements.